A graphical method for mapping bioregulatory networks is presented that is suited for the representation of multimolecular complexes, protein modifications, as well as actions at cell membranes and between protein domains. The symbol conventions defined for these molecular interaction maps are designed to accommodate multiprotein assemblies and protein modifications that can generate combinatorially large numbers of molecular species. Diagrams can either be “heuristic,” meaning that detailed knowledge of all possible reaction paths is not required, or “explicit,” meaning that the diagrams are totally unambiguous and suitable for simulation. Interaction maps are linked to annotation lists and indexes that provide ready access to pertinent data and references, and that allow any molecular species to be easily located. Illustrative interaction maps are included on the domain interactions of Src, transcription control of E2F-regulated genes, and signaling from receptor tyrosine kinase through phosphoinositides to Akt/PKB. A simple method of going from an explicit interaction diagram to an input file for a simulation program is outlined, in which the differential equations need not be written out. The role of interaction maps in selecting and defining systems for modeling is discussed.
REFERENCES
1.
K. W.
Kohn
, “Molecular interaction map of the mammalian cell cycle control and DNA repair systems
,” Mol. Biol. Cell
10
, 2703
(1999
).2.
K. W.
Kohn
, “Functional capabilities of molecular network components controlling the mammalian G1/S cell cycle phase transition
,” Oncogene
16
, 1065
(1998
).3.
D.
Bray
, “Signaling complexes: Biophysical constraints on intracellular communication
,” Annu. Rev. Biophys. Biomol. Struct.
27
, 59
(1998
).4.
T.
Pawson
and P.
Nash
, “Protein-protein interactions define specificity in signal transduction
,” Genes Dev.
14
, 1027
(2000
).5.
G.
Wang
, U. S.
Bhalla
, and R.
Iyengar
, “Complexity in biological signaling systems
,” Science
284
, 92
(1999
).6.
D.
Bray
and S.
Lay
, “Computer-based analysis of the binding steps in protein complex formation
,” Proc. Natl. Acad. Sci. U.S.A.
94
, 13493
(1997
).7.
C. J.
Morton-Firth
and D.
Bray
, “Predicting temporal fluctuations in an intracellular signalling pathway
,” J. Theor. Biol.
192
, 117
(1998
).8.
H. H.
McAdams
and A.
Arkin
, “It’s a noisy business! Genetic regulation at the nanomolar scale
,” Trends Genet.
15
, 65
(1999
).9.
P. H.
Kussie
, S.
Gorina
, V.
Marechal
et al., “Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain
,” Science
274
, 948
(1996
).10.
T.
Pawson
and J. D.
Scott
, “Signaling through scaffold, anchoring, and adaptor proteins
,” Science
278
, 2075
(1997
).11.
A. J.
Whitmarsh
and R. J.
Davis
, “Structural organization of MAP-kinase signaling modules by scaffold proteins in yeast and mammals
,” Trends Biochem. Sci.
23
, 481
(1998
).12.
W.
Xu
, A.
Doshi
, M.
Lei
et al., “Crystal structures of c-Src reveal features of its autoinhibitory mechanism
,” Molec. Cell
3
, 629
(1999
).13.
S.
Gonfloni
, A.
Weijland
, J.
Kretzschmar
et al., “Crosstalk between the catalytic and regulatory domains allows bidirectional regulation of Src
,” Nat. Struct. Biol.
7
, 281
(2000
).14.
D. A.
Tice
, J. S.
Biscardi
, A. L.
Nickles
et al., “Mechanism of biological synergy between cellular Src and epidermal growth factor receptor
,” Proc. Natl. Acad. Sci. U.S.A.
96
, 1415
(1999
).15.
X.-M.
Zheng
, R. J.
Resnick
, and D.
Shalloway
, “A phosphotyrosine displacement mechanism for activation of Src by PTPalpha
,” EMBO J.
19
, 964
(2000
).16.
L. A.
Cary
and J. A.
Cooper
, “Molecular switches in lipid rafts
,” Nature (London)
404
, 945
(2000
).17.
M.
Kawabuchi
, Y.
Satomi
, T.
Takao
et al., “Transmembrane phosphoprotein Cbp regulates the activities of Src-family tyrosine kinases
,” Nature (London)
404
, 999
(2000
).18.
S.
Takeuchi
, Y.
Takayama
, A.
Ogawa
et al., “Transmembrane phosphoprotein Cbp positively regulates the activity of the carboxyl-terminal Src kinase, Csk
,” J. Biol. Chem.
275
, 29183
(2000
).19.
J. S.
Biscardi
, D. A.
Tice
, and S. J.
Parsons
, “c-Src, receptor tyrosine kinases, and human cancer
,” Adv. Cancer Res.
76
, 61
(1999
).20.
N.
Dyson
, “The regulation of E2F by pRB-family proteins (Review)
,” Genes Dev.
12
, 2245
(1998
).21.
K.
Ohtani
, “Implications of transcription factor E2F in regulation of DNA replication
,” Front. Biosci.
4
, d793
(1999
).22.
H.
Muller
and K.
Helin
, “The E2F transcription factors: Key regulators of cell proliferation
,” Biochim. Biophys. Acta
1470
, M1
(2000
).23.
S.
He
, B. L.
Cook
, B. E.
Deverman
et al., “E2F is required to prevent inappropriate S-phase entry of mammalian cells
,” Mol. Cell. Biol.
20
, 363
(2000
).24.
G.
Marzio
, C.
Wagener
, I.
Gutierrez
et al., “E2F family members are differentially regulated by reversible acetylation
,” J. Biol. Chem.
275
, 10887
(2000
).25.
J.
Karlseder
, H.
Rotheneder
, and E.
Wintersberger
, “Interaction of Sp1 with the growth- and cell cycle-regulated transcription factor E2F
,” Mol. Cell. Biol.
16
, 1659
(1996
).26.
S-Y.
Lin
, A. R.
Black
, D.
Kostic
et al., “Cell cycle-regulated association of E2F1 and Sp1 is related to their functional interaction
,” Mol. Cell. Biol.
16
, 1668
(1996
).27.
G.
Watanabe
, C.
Albanese
, R. J.
Lee
et al., “Inhibition of cyclin D1 kinase activity is associated with E2F-mediated inhibition of cyclin D1 promoter activity through E2F and Sp1
,” Mol. Cell. Biol.
18
, 3212
(1998
).28.
R. X.
Luo
, A. A.
Postigo
, and D. C.
Dean
, “Rb interacts with histone deacetylase to repress transcription
,” Cell
92
, 463
(1998
).29.
A.
Brehm
, E. A.
Miska
, D. J.
McCanee
et al., “Retinoblastoma protein recruits histone deacetylase to repress transcription
,” Nature (London)
391
, 597
(1998
).30.
Y.
Takahashi
, J. B.
Rayman
, and B. D.
Dynlacht
, “Analysis of promoter binding by the E2F and pRB families in vivo: Distinct E2F proteins mediate activation and repression
,” Genes Dev.
14
, 804
(2000
).31.
S. R.
Datta
, A.
Brunet
, and M. E.
Greenberg
, “Cellular survival: A play in three Akts
,” Genes Dev.
13
, 2905
(1999
).32.
B.
Fadeel
, B.
Zhivotovsky
, and S.
Orrenius
, “All along the watchtower: On the regulation apoptosis regulators
,” FASEB J.
13
, 1647
(1999
).33.
I.
Galetic
, M.
Andjelkovic
, R.
Meier
et al., “Mechanism of protein kinase B activation by insulin/insulin-like growth factor-1 reavealed by specific inhibitors of phosphoinositide-3-kinase—Significance for diabetes and cancer
,” Pharmacol. Therap.
82
, 409
(1999
).34.
35.
M.
Andjelkovic
, S-M.
Maira
, P.
Cron
et al., “Domain swapping used to investigate the mechanism of protein kinase B regulation by 3-phosphoinositide-dependent protein kinase 1 and Ser473 kinase
,” Mol. Cell. Biol.
19
, 5061
(1999
).36.
G.
Tzivion
, Z.
Luo
, and J.
Avruch
, “A dimeric 14-3-3 protein is an essential cofactor for Raf kinase activity
,” Nature (London)
394
, 88
(1998
).37.
G.
Carpenter
, “The EGF receptor: A nexus for trafficking and signaling
,” BioEssays
22
, 697
(2000
).38.
T. O.
Chan
, S. E.
Rittenhouse
, and P. N.
Tsichlis
, “Akt/PKB and other D3 phosphoinositide-regulated kinases: Kinase activation by phosphoinositide-dependent phosphorylation
,” Annu. Rev. Biochem.
68
, 965
(1999
).39.
L. E.
Rameh
and L. C.
Cantley
, “The role of phosphoinositide 3-kinase lipid products in cell function
,” J. Biol. Chem.
274
, 8347
(1999
).40.
R. A.
Anderson
, I. V.
Boronenkov
, S. D.
Doughman
et al., “Phosphatidylinositol phosphate kinases, a multifaceted family of signaling enzymes
,” J. Biol. Chem.
274
, 9907
(1999
).41.
T. F. J.
Martin
, “Phosphoinositide lipids as signaling molecules: Common themes for signal transduction, cytoskeletal regulation, and membrane trafficking
,” Annu. Rev. Cell Dev. Biol.
14
, 231
(1998
).42.
T. Itoh et al., “Autophosphorylation of type I phosphatidylinositol phosphate kinase regulates its lipid kinase activity,” J. Biol. Chem. (Published electronically on 20 April 2000 as manuscript M000426200) (2000).
43.
D. A.
Fruman
, R. E.
Meyers
, and L. C.
Cantley
, “Phosphoinositide kinases
,” Annu. Rev. Biochem.
67
, 481
(1998
).44.
S. J.
Leevers
, B.
Vanhaesebroeck
, and M. D.
Waterfield
, “Signalling through phosphoinositide 3-kinases: The lipids take centre stage
,” Curr. Opin. Cell Biol.
11
, 219
(1999
).45.
M. F.
Aman
, T. D.
Lamkin
, H.
Okada
et al., “The inositol phosphatase SHIP inhibits Akt/PKB activation in B cells
,” J. Biol. Chem.
273
, 33922
(1998
).46.
S. M.
Jones
, R.
Klinghoffer
, G. D.
Prestwich
et al., “PDGF induces an early and a late wave of PI 3-kinase activity, and only the late wave is required for progression through G1
,” Curr. Biol.
9
, 512
(1999
).
This content is only available via PDF.
© 2001 American Institute of Physics.
2001
American Institute of Physics
You do not currently have access to this content.
